{"@context":"https://schema.org","@type":"Article","headline":"Part 2 non-member prescriber medication response","description":"Learn the program contacts, SUD medication type and dosage, and relevant dates a registry may return to a qualifying non-member treating provider.","url":"https://finnihealth.com/resources/glossary/part-2-non-member-prescriber-medication-response","datePublished":"2026-08-17T00:00:00.000Z","dateModified":"2026-08-24T00:00:00.000Z","author":{"@type":"Organization","name":"Finni Health Editorial Team"},"publisher":{"@type":"Organization","name":"Finni Health","url":"https://www.finnihealth.com"},"isPartOf":{"@type":"CollectionPage","name":"ABA and Practice Operations Glossary","url":"https://www.finnihealth.com/resources/glossary"},"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Resources","item":"https://www.finnihealth.com/resources"},{"@type":"ListItem","position":2,"name":"Glossary","item":"https://www.finnihealth.com/resources/glossary"},{"@type":"ListItem","position":3,"name":"Part 2 non-member prescriber medication response","item":"https://finnihealth.com/resources/glossary/part-2-non-member-prescriber-medication-response"}]}}
Glossary term

Part 2 non-member prescriber medication response

Learn the program contacts, SUD medication type and dosage, and relevant dates a registry may return to a qualifying non-member treating provider.

5
min read
Updated
August 23, 2026
Sources checked
August 23, 2026
· View sources
Also called

central registry medication and dates disclosure outside provider SUD prescription response

A non member medication response under 42 CFR 2.34 may tell a qualifying non-member treating provider the name, address, and telephone number of the member program where the patient is enrolled; the type and dosage of SUD medication administered or prescribed there; and relevant administration or prescription dates. The response should match the verified query purpose and exclude unrelated medications, notes, diagnoses, and narrative.

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.34(d) defines the registry response to a qualifying non-member treating provider. It may include the enrolled member program's name, address, and telephone number; the type and dosage of SUD medication administered or prescribed; and relevant administration or prescription dates. The rule also permits necessary communication to verify or prevent multiple enrollment or improper prescribing.

Use a controlled field set

Current § 2.34(d) defines the response. Create explicit fields for member-program contact, SUD medication, dosage with units and form, and relevant dates. Preserve the source record, clinical author, currency, and correction history.

Keep clinical meaning intact

Avoid truncating units, confusing administered with prescribed, merging active and discontinued medications, or presenting old dates as current. A qualified clinician or pharmacist should resolve clinical ambiguity; registry staff should not infer a regimen.

Limit follow-up communication

The registry and treating prescriber may communicate as necessary to verify error and address multiple enrollment or improper prescribing. The HHS fact sheet does not turn that exchange into full-record access. Log each additional field and purpose.

Build a field-level response

Create an allowlist for program name, address, telephone number, SUD medication type, dosage value, units, form or route when needed to preserve meaning, and relevant administration or prescription dates. Map each field to an authoritative source, owner, timestamp, code set, and correction process.

Exclude unrelated prescriptions, diagnoses, counseling notes, laboratory results, payer data, full medication lists, attachments, and narrative. Test hidden metadata, interface defaults, logs, support tools, and exports as well as the visible response.

Preserve clinical accuracy

Differentiate prescribed from administered medication, current from discontinued therapy, orders from actual administrations, and corrections from later changes. Keep dosage value, unit, concentration, formulation, frequency where essential to interpret the dosage, and time context together. Do not let a truncated display change clinical meaning.

Qualified clinical or pharmacy staff should resolve ambiguity within their scope. Registry staff and software should not infer a regimen or recommend a prescribing action.

Match the response to the query

Link every response to the authenticated requester, treating relationship, patient match, listed purpose, member-program enrollment, source records, payload version, secure route, timestamp, and approver. Confirm that the data are current enough for the decision and clearly state their effective dates.

Hold the response when identity, enrollment, medication, dosage, date, purpose, or requester evidence conflicts. An urgent request may require prompt escalation, but urgency does not make uncertain data reliable.

Manage necessary follow-up

The registry and provider may communicate as necessary to verify or prevent multiple enrollment or improper prescribing. Authenticate each participant, keep questions tied to that purpose, record corrections and clinical concerns, and document the resulting decision or handoff. Use separate authority for broader records.

When the provider reports an error, contain the incorrect response, check the source, issue a linked correction through the approved route, notify affected parties as appropriate, and verify receipt.

Audit response quality and use

Sample successes, no matches, holds, denials, retries, corrections, and urgent escalations. Check requester and relationship evidence, purpose, exact payload, source accuracy, secure delivery, acknowledgments, follow-up, and closure. Include omitted or misleading medication details as well as excess disclosure.

Monitor repeated queries, bulk access, unusual requester patterns, stale contact data, unsupported medications, unit conversion problems, and responses that enter unrestricted systems. Review interface changes before release.

Provide the requester a clear contact for urgent discrepancy reporting without inviting an open-ended record request. Time the response and correction workflow according to clinical risk, then preserve who received the final verified information.

Example

Fourteen responses are tested. Twelve match the member program, medication, dosage, dates, source, requester, and purpose; two include the full medication list. Response compliance is 12 of 14 messages.

Medication-response checklist

  • allow only member-program contact, SUD medication type and dosage, and relevant dates;
  • preserve source, currency, prescribed-versus-administered status, units, and meaning;
  • link the response to requester, treating relationship, patient match, and purpose;
  • hold conflicts and route clinical ambiguity to qualified staff;
  • limit follow-up to verifying or preventing enrollment or improper prescribing; and
  • audit omissions, excess fields, corrections, retries, delivery, and downstream use.

The response supports a treating provider's decision with defined facts. It is not a medication recommendation or a substitute for clinical verification.

Related terms

Sources

Beyond the glossary

Take the next step with clarity

Whether you are finding care, growing as a clinician, or building a stronger ABA practice, Finni brings the people, tools, and support together to help you move forward.

Start or grow your ABA practice with Finni